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ABSTRACT 
Obesity is a health problem of affluence, of worldwide prevalence and is considered as 
the insidious creeping pandemic which is now engulfing the entire world. Obesity 
induces oxidative stress which is partly responsible for morbidities. The modern science 
fails to give a safe and effective remedy. Ayurveda can pave a way towards attaining the 
goal. In Ayurveda Charaka has mentioned Musta (Cyperusrotundus Linn.) in 
Lekhaniyamahakashay i.e. drugs acting as scraping agents. The rhizomes of Musta 
(Cyperusrotundus Linn.) contains flavonoids, ascorbic acid and polyphenol which are 
responsible for its anti oxidant activity. Open labelled study was done on 60 patients at 
Ayurved Mahavidyalaya Sion, Mumbai-22 for duration of 90 days. Out of 60 patients, 30 
were advised to take Mustachurna 3 gm thrice a day with warm water along with diet 
and exercise while 30 patients were advised diet and exercise only. Monthly assessment 
was done on the basis of signs and symptoms like Atitrushna (excessive Thirst), 
Atiksudha (excessive hunger), Atinidra (excessive sleepiness), Atisveda (excessive 
sweating), Daurgandhya (excessive body odour), Anutsaha (laziness), Daurbalya 
(tiredness) and Kshudraswasa (breathlessness). Objective improvement was done on 
the basis of BMI, Waist: Hip ratio, and MDA (Malondialdehyde), GSH (glutathione 
peroxidase) enzyme study for oxidant activity at baseline and at the end of study (after 
90 days). Subjective improvement is shown in percentage. Paired t test was applied to 
objective parameters which was highly significant at 1% level of significance i.e. 
p<0.01.in patients taking Mustachurna while in other group it was significant at 5% 
level of significance, concluding Mustachurna definitely has anti-obesity and anti-
oxidant activity.  
Key words: Obesity, oxidative stress, Musta (Cyperusrotundus Linn.), anti-oxidant, MDA, 
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INTRODUCTION
                       Obesity is emerging as an important 
health problem in India. Twenty two millions 
Indian are obese, especially abdominally 
obese.[1] The incidence of obesity is increasing 
day by day due to irregular eating habits and 
sedentary life style.[2] Obesity is chronic and 
increasingly common medical condition in which 
excess body fat has accumulated to the extent it 
may have a negative effect on health leading to 
reduced life expectancy and/ or increased health 
problems.[3] The signs and symptoms of obesity 
described in Charakasamhita are Atitrushna 
(Excessive Thirst), Atiksudha (Excessive 
Hunger), Atinidra (Excessive Sleepiness), 
Atisveda (Excessive Sweating), Daurgandhya 
(Excessive Body Odour), Anutsaha (Laziness), 
Daurbalya (Tiredness) and Kshudraswasa 
(Breathlessness).[4] Presently commonly used 
objective methods of estimating obesity are 
Body mass index and waist to hip ratio.[1] People 
are considered obese when their BMI a 
measurement obtained is equal to or more than 
25 to 30[5] The desired waist to hip ratio in 
women is <0.8 and <1.0 in men. It is mostly 
primary, that is, no obvious cause exists other 
than an imbalance between energy intake and 
energy expenditure. Obesity has reached 
epidemic proportions in India in the 21st century 
with morbid obesity affecting 5% of the 
country’s population[6]. It is a leading 
preventable cause of death worldwide, with 
increasing rates in adults and children. 
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Authorities view it as one of the most serious 
public health problems in 21st century. [7, 8]  
                       In modern medical sciences, the 
classical treatment of obesity is only diet and 
exercise. If it doesn’t work then anti obesity 
drugs are given which are least effective with 
drastic side effects[9]. Free radical-induced 
oxidative damage has been suggested to play a 
major role in the pathogenesis of obesity [10]. 
Ayurvedic drugs like Shatavari, Guduchi, 
Gokshur, Ashwagandha, Pippali, Amalaki, Dadim, 
Tulsi, Haritaki etc. also possess anti-oxidant 
properties [11]. Musta (Cyperusrotundus Linn.) is 
one such drug. It is a rich source of flavonoids, 
ascorbic acid andpolyphenol which are 
responsible for its anti-oxidantactivity.[12] 
Charaka has described Musta in Lekhaniya 
Mahakashay. The fat in the body is scraped 
digested and destroyed. Musta is a plant having 
Katu, Tikta, Kashay rasa, Katuvipaka, Shitavirya 
and Laghuguna. It has properties like Lekhana 
(scraping agent), Dipana, Pachana which plays 
major role in Sthaulya (obesity)[13] 
MATERIALS AND METHODS 
Selection of cases 
 There was random selection of patient 
from O.P.D. and I.P.D. of R.V. Ayurvedic hospital, 
Sion; Mumbai-22. Study was carried out as per 
Ethical Clearance Number – AMS /1354/11-12. 
Type of study: Openlabeled study. 
Total no of cases: 60  
Duration of study-90 Days 
Inclusive criteria  
 Either sex 
 Age between 18-60 years 
 BMI: Between 25-40 
 Informed consent signed 
Exclusive criteria   
 Age less than 18 years and more than 60 
years 
 Pregnant women and lactating mother. 
 Patients with renal and hepatic dysfunction. 
 Obesity due to hypothyroidism or Cushing’s 
syndrome. 
 Secondary obesity 
 HIV-AIDS 
 On drugs: Insulin dependent, anti 
depressant, or steroid dependent patients. 
 BMI more than 40 
Drug source: Rhizomes of Musta 
(Cyperusrotundus Linn.) 
Formulation: Churna (powder) of Musta 
(Cyperusrotundus Linn.) 
Mode of administration: Oral. 
Dose: 3 gm TDS 
Anupan: Koshnodak (Warm water) 
Follow up: Clinical follow-up was advised every 
30 days in duration of 90 days. 
Statistical test   
Statistical analysis was done by applying 
Paired t-test to objective parameters: at baseline 
and at the end of study (after 90 days). 
Subjective improvement has been shown in 
percentage[14] 
Assessment of efficacy 
Subjective improvement 
 Monthly assessment was done with the help of 
reduction in following symptoms. 
 Atitrushna (Excessive Thirst) 
 Atiksudha (Excessive Hunger) 
 Atinidra (Excessive Sleepiness) 
 Atisveda (Excessive Sweating) 
 Daurgandhya (Excessive Body Odour) 
 Anutsaha (Laziness) 
 Daurbalya (Tiredness)  
 Kshudraswasa (Breathlessness) 
Objective improvement  
 BMI 
 Waist: Hip ratio 
 For antioxidant Study: MDA, GSH enzyme 
study 
Gradation of symptoms [15] 
(1) Atitrushna (Excessive Thirst) 
0- thirst can be controlled 
1-thirst can be controlled for some time 
 2-thirst is unbearable 
 3-thirst is unbearable with dryness in throat 
and mouth 
(2) Atishudha (Excessive Hunger) 
0-Severe Hunger during meal times 
1-Severe hunger between two meal times 
2-Having hunger pangs frequently between 
meals 
3- Hunger pangs immediately after meals 
(3) Atinidra (Excessive sleepiness) 
0- 8 hours sleep 
1- 10 hours sleep 
2-More than 12 hours of sleep 
3- More than above 
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(4) Atisveda (Excessive Sweating) 
 0- Sweating after running 
1- Sweating after walking 500 meters 
2- Sweating after walking 100 meters 
3- Sweating even when stationary 
(5) Daurgandhya(Excessive Body Odour) 
0- Realized by patient only 
1-Realized by others around him 
2- Realized by others at a radius of 1 meter  
3-Realized by others at a radius greater than 
1 meter 
(6) Anutsaha (Laziness) 
 0- feels like working and works 
 1-Does not feel like working but may work 
2-Does not feel like working  
3-Does notwork at all 
(7) Daurbalya (Weakness) 
0-Tiredness after climbing 30 stairs 
1- Tiredness after climbing 20 stairs 
2- Tiredness after climbing 10 stairs 
3- Tiredness after walking small distance 
 (8) Kshudrashwasa (Breathlessness) 
 0- Breathlessness after climbing 30 stairs 
1- Breathlessness after climbing 20 stairs 
2- Breathlessness after climbing 10 stairs 
3-Breathlessness after walking small 
distance 
RESULTS 
Table 1: Chart Showing % Improvement 
In Symptoms 
Symptoms Group A Group B 
Excessive thirst 69.23% 33.33% 
Excessive hunger 85.19% 34.48% 
Excessive sleep 60.87% 33.33% 
Excessive sweat 33.33% 50.00% 
Body odour 46.67% 38.89% 
Laziness 100.00% 31.25% 
Tiredness  100.00% 29.63% 
Breathlessness 96.30% 17.86% 
Table 2: BMI Analysis 
  Decreased No change Increased 
Group A 86.67% 3.33% 10.00% 
Group B 73.33% 20.00% 6.67% 
Table 3: Statistical analysis for BMI 
Table 4: Analysis of Waist: hip 
 Decreased No change Increased 
Group A 80.00% 13.33% 6.67% 
Group B 66.67% 6.67% 26.67% 
Table 5: Statistical analysis of Waist: hip 
Table 6: MDA analysis 
 Decreased No change Increased 
Group A 96.67% 3.45% 0.00% 
Group B 60.00% 0.00% 40.00% 
Table 7: Statistical analysis of MDA 
Table 8: GSH analysis 
  Decreased No change Increased 
Group A 96.67% 0.00% 3.33% 
Group B 60.00% 0.00% 40.00% 
Table 9: Statistical analysis of GSH 
DISCUSSION 
Out of 60 patients 7 [11.67%] were 
males and 53 [88.33%] were females. Age wise 
categorisation showed that 31.67% were 
between 18-30 years of age, 23.33% between 
31-40 years of age, 16.67% between 41-50 years 
of age and 28.33% between 51-60 years of age. 
According to physical activity: Heavy worker: 
11.67 %, Moderate worker: 46.67%, Sedentary 
worker: 41.67%. Diet wise distribution shows 
that 38.33% 0f subjects have a vegetarian diet 
and 61.67% have mixed diet. 
Subjective evaluation showed all the 30 
patients of group A showed reduction in 
 Mean SD SE t value 
Group A 1.64 1.49 0.27 6.06 
Group B 0.67 1.27 0.23 2.88 
 Mean SD SE t value 
Group A 0.03 0.004 1.45 7.21 
Group B 0.01 0.09 0.00 1.46 
 MEAN SD SE t value 
Group A 1.86 1.16 0.21 8.80 
Group B 0.13 0.48 0.09 1.42 
 Mean SD SE t value 
Group A 13.22 7.28 1.33 9.95 
Group B 3.28 6.49 1.18 2.77 
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Breathlessness, laziness and tiredness. 69.23% 
showed decrease in excessive thirst, 85.19% 
showed decrease in excessive hunger, 60.87% 
showed decrease in excessive sleepiness, 
33.33% showed decrease in excessive sweat and 
46.67% showed decrease in body odour. While 
in Group B out of 30 patients 33.33% subjects 
showed decrease in excessive thirst and sleep, 
34.48% showed decrease in excessive hunger, 
50% showed decrease in excessive sweat, 
38.89% showed decrease in body odour, 31.25% 
showed decrease in laziness, only 29.63% 
showed decrease in tiredness, and only 17.86% 
showed decrease in breathlessness. Thus 
patients Group A showed more symptomatic 
relief than patients Group B. In objective 
evaluation the BMI of Group A patients was 
reduced significantly, t value = 6.06 at 1 % level 
of significance i.e. p<0.01.While BMI of Group B 
patients was reduced less as compared to Group 
A, t value= 2.88 at 5 % level of significance i.e. 
p<0.05.  
Waist: Hip ratio of Group A patients was 
reduced significantly, t value = 7.21 at 1% level 
of significance i.e. p< 0.01.WhileWaist: Hip ratio 
of Group B patients was reduced less as 
compared to Group A patients, t value=1.46 at 
5% level of significance i.e. p< 0.05.Out of 30 
patients in group A 96.67% showed decrease in 
MDA value, 3.45% showed no change and not a 
single subject showed increase in MDA. While in 
Group B Out of 30 patients 60% showed 
decrease in MDA value and 40% showed 
increase in MDA value The statistical test is 
found to be highly significant for Group A at 
p<0.01 while the statistical test for Group B was 
not significant. 
In Ayurveda many drugs are described as 
Lekhaniya and Medoghna like Haridra, 
Daruharidra, Haritki etc. Musta is a one of the 
drug which show Slekhaniya and anti-oxidant 
activity. Musta has Tikta, Katu rasa, Katuvipaka, 
Shitavirya and Laghu, Rukshaguna. It alleviates 
Kapha and Pitta dosas and aggravates Vatadosha. 
The rhizomes of Musta contains flavonoids, 
ascorbic acid and polyphenol which shows anti-
oxidant properties. Due to Tikta and Katu rasa it 
repairs altered Jatharagni and Medodhatvagni. 
Laghu, Ruksha guna absorbs all the water 
content from Meda and Kapha. Also due to Katu 
rasa it digests Meda and Kapha. All these 
properties vitiate Vatadosha. To avoid that 
Musta is given with warm water. Flavonoids, 
ascorbic acid and polyphenol present in Musta 
scavenge free radicals from the body and reduce 
oxidative stress. From the above case studies of 
60 patients the anti-oxidant activity of Musta can 
be proved. It definitely reduces the signs and 
symptoms of oxidative stress induced obesity. 
There were no major adverse events noted with 
Musta. There were some minor problems 
encountered by the patients taking Musta. It was 
noted that a few patients experienced nauseating 
sensation while ingesting Musta for first 3-4 
days. Some could not tolerate its smell. But all 
these symptoms abated after 3-4 days. Further 
research needs to be done to make Musta more 
palatable. 
CONCLUSION 
After studying 60 patients for 90days following 
points were concluded.  
1. Patients taking Musta churna have shown 
considerable decrease in subjective (signs 
and symptoms) and objective parameters 
(BMI and Hip waist ratio) as compared to 
other group. Musta having Tikta, Katu rasa, 
Katuvipaka and Laghu Ruksha guna burns 
and metabolizes fat, improves process of fat 
metabolism, chelates already present fat and 
removes it out of the body. Thus Musta 
definitely has anti-obesity activity. 
2. Musta reduces oxidative stress by scavenging 
free radicals and terminating chain reaction. 
There was considerable decrease in MDA 
values and good increase in GSH values in 
patients taking Mustachurna. Polyphenols 
and ascorbic acid present in Musta may be 
responsible for this. 
3. The drug does not showed any toxic effects. 
4. Thus Musta definitely has positive effect in 
reducing signs and symptoms of oxidative 
stress induced obesity. 
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